Dilazep

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Dilazep
Dilazep.png
Clinical data
Trade namesComelian Kowa
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC31H44N2O10
Molar mass604.69 g/mol g·mol−1
3D model (JSmol)
  (verify)

Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]

It is used for the treatment of cardiopathy and renal disorders.[2]

See also[edit]

References[edit]

  1. ^ Hiroshi Deguchi; Hiroyuki Takeya; Hideo Wada; Esteban C. Gabazza; Nobuyuki Hayashi; Hajime Urano; Koji Suzuki (September 15, 1997). "Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes". Blood. 90: 2345–2356.
  2. ^ kowa pharmaceuticals